Basic Information
ID: ALA4829083
Type: Binding
Description: Inhibition of gp120 in HIV-1 NL4-3 HXB-2-Luc pseudotyped virus infected in human TZM-bl cells assessed as reduction in viral infection pretreated for 30 mins before viral infection and measured after 3 days by luciferase based single cycle infection assay
Organism: HIV-1 M:B_HXB2R
Strain: NL4-3
Cell type: TZM-bl
Activity Charts
Bioactivity
Activity Types for Assay ALA4829083
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 337.85 | 2.70 | 2.70 |
| 403.55 | 2.95 | 2.95 |
| 364.86 | 2.51 | 2.51 |
| 348.47 | 2.44 | 2.44 |
| 389.52 | 3.02 | 3.02 |
| 368.85 | 1.74 | 1.74 |
| 346.84 | 3.22 | 3.22 |
| 368.85 | 1.35 | 1.35 |
| 318.18 | 2.16 | 2.16 |
| 386.84 | 0.86 | 0.86 |
| 389.52 | 3.02 | 3.02 |
| 321.78 | 2.96 | 2.96 |
| 330.41 | 1.85 | 1.85 |
| 348.47 | 2.44 | 2.44 |
| 478.54 | 4.51 | 4.51 |
| 382.87 | 1.74 | 1.74 |
| 382.87 | 1.74 | 1.74 |
| 450.49 | 3.66 | 3.66 |
| 427.78 | 1.19 | 1.19 |
| 330.41 | 1.85 | 1.85 |
| 346.84 | 3.22 | 3.22 |
| 368.85 | 1.35 | 1.35 |
| 350.83 | 2.20 | 2.20 |
| 403.55 | 2.95 | 2.95 |
| 478.54 | 4.51 | 4.51 |
| 377.89 | 4.51 | 4.51 |
| 368.85 | 1.74 | 1.74 |
| 388.54 | 3.06 | 3.06 |
| 350.83 | 2.20 | 2.20 |
| 364.86 | 2.51 | 2.51 |
| 388.54 | 3.06 | 3.06 |
| 386.84 | 0.86 | 0.86 |
| 427.78 | 1.19 | 1.19 |